Claris Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$118M
- Investors
-
10
Claris Bio General Information
Description
Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. The company's technology creates a recombinant hepatocyte growth factor that accelerates the healing process, enabling healthcare professionals to get access to noninvasive treatment and patients to recover and stay fit.
Contact Information
Website
www.clarisbio.comCorporate Office
- 475 Magellan Avenue
- Half Moon Bay, CA 94019
- United States
Corporate Office
- 475 Magellan Avenue
- Half Moon Bay, CA 94019
- United States
Claris Bio Timeline
Claris Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 24-Jul-2026 | $118M | Completed | Clinical Trials - General | ||
| 3. Debt - General | 22-Sep-2025 | Completed | Clinical Trials - General | |||
| 2. Debt - General | 07-Mar-2025 | $3.3M | $57.8M | Completed | Clinical Trials - General | |
| 1. Later Stage VC (Series A) | 04-Jan-2024 | $54.5M | $54.5M | Completed | Clinical Trials - General |
Claris Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A3 | ||||||||
| Series A-2 | 25,292,580 | $0.000100 | $0.64 | $0.64 | $0.64 | 5.48% | ||
| Series A-1 | 39,714,280 | $0.000100 | $0.44 | $0.44 | $0.44 | 8.6% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Claris Bio Patents
Claris Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026030528-A1 | Activated hepatocyte growth factor | Pending | 01-Aug-2024 | ||
| WO-2026030518-A1 | Methods for improved gene insertion and expression in cell lines | Pending | 01-Aug-2024 | ||
| AU-2022272740-A1 | Compositions of growth factor for the treatment of eye disease | Pending | 14-May-2021 | ||
| AU-2022272740-A9 | Compositions of growth factor for the treatment of eye disease | Pending | 14-May-2021 | ||
| CA-3218000-A1 | Compositions of growth factor for the treatment of eye disease | Pending | 14-May-2021 | A61K38/1825 |
Claris Bio Signals
Claris Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adage Capital Management | Hedge Fund | Minority | ||
| ADAR1 Capital Management | Hedge Fund | Minority | ||
| Aisling Capital | Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| Samsara BioCapital | Venture Capital | Minority |
Claris Bio FAQs
-
When was Claris Bio founded?
Claris Bio was founded in 2018.
-
Where is Claris Bio headquartered?
Claris Bio is headquartered in Half Moon Bay, CA.
-
What is the size of Claris Bio?
Claris Bio has 8 total employees.
-
What industry is Claris Bio in?
Claris Bio’s primary industry is Biotechnology.
-
Is Claris Bio a private or public company?
Claris Bio is a Private company.
-
What is the current valuation of Claris Bio?
The current valuation of Claris Bio is .
-
What is Claris Bio’s current revenue?
The current revenue for Claris Bio is .
-
How much funding has Claris Bio raised over time?
Claris Bio has raised $178M.
-
Who are Claris Bio’s investors?
Adage Capital Management, ADAR1 Capital Management, Aisling Capital, Catalio Capital Management, and Samsara BioCapital are 5 of 10 investors who have invested in Claris Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process